Q3 2025 adjusted EBITDA declined year-over-year, but year-to-date EBITDA improved. New contracts and extensions drove a strong order intake, and a cash dividend was declared. Outlook for 2026 remains positive due to a solid backlog.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.